Director, HTA, Value & Evidence (HV&E) – Breast Cancer
Pfizer
About this role
A Director of Health Technology Assessment, Value & Evidence (HTA) in the Breast Cancer space at Pfizer focuses on developing and executing global evidence generation strategies to support optimal patient access to breast cancer medicines, particularly Ibrance. The role involves strategic guidance, robust evidence development, and collaboration across teams to ensure successful market access and reimbursement.
Skills
Qualifications
About Pfizer
pfizer.comBreakthroughs that change patients’ lives.
Recent company news
Mackenzie Financial Corp Raises Holdings in Pfizer Inc. $PFE
4 hours ago
Pfizer's Payout Ratio Is Still Over 100%. Is a Dividend Cut Inevitable?
2 days ago
Pfizer’s Weight Management Drug Wins China Approval
10 hours ago
Pfizer Inc. | Pharmaceuticals, Vaccines & Company History | Britannica Money
2 weeks ago
Pfizer Stock: Cheap For A Reason (NYSE:PFE)
1 day ago
About Pfizer
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Pfizer.
Salary
$177k – $294k
per year
More jobs at Pfizer
Similar Jobs
HTA Evidence Synthesis Statistician (2 open roles)
Diversity Employment
Associate Consultant, HTA/HEOR/RWE
IQVIA
Lead Consultant, HTA ( Health Technology Assessment)
Clarivate
Manager - HEVA (Evidence Synthesis)
Sanofi
(Senior) Health Technology Assessment (HTA) Strategy Manager (m/w/d)
Eli Lilly and Company
HTA & Modelling Science Lead
AstraZeneca